BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PRGN-2009 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PRGN-2009\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06223568-10976@assetmemo.bio
DTSTAMP:20261121T005821Z
DTSTART;VALUE=DATE:20280110
DTEND;VALUE=DATE:20280111
SUMMARY:PRGN-2009: Phase 2 readout est. (NCT06223568)
DESCRIPTION:PRGN-2009\, phase 2.\nStudy: Phase II Trial of Neoadjuvant Chem
 otherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-200
 9 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and 
 Neck) Cancer\nEstimated primary completion: 10 January 2028. This is a Cli
 nicalTrials.gov estimate\, not a confirmed readout date\, and it can move.
 \nDrug page: https://assetmemo.bio/drug/prgn-2009#upcoming-events\nRegistr
 y record: https://clinicaltrials.gov/study/NCT06223568
URL:https://assetmemo.bio/drug/prgn-2009#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
